FDA Clears SOMATOM go. CT Platform


The Food and Drug Administration (FDA) has cleared the SOMATOM go. computed tomography (CT) platform from Siemens Healthineers – an entirely new CT platform designed for highly diverse sets of user needs. Created with extensive customer feedback, the new platform includes the SOMATOM go.Now and SOMATOM go.Up CT scanners, which offer automated, standardized workflows that help users achieve more consistent, profound clinical results at a lower total cost of ownership. The tablet-based workflow concept facilitates more comprehensive patient care and allows radiology providers to use a cost-efficient single-room concept for the first time.

The 32-slice SOMATOM go.Now CT scanner is particularly suited to radiology providers who want to leverage a low-cost but clinically robust CT solution. With a wide detector that provides up to 64 slices, the SOMATOM go.Up offers faster scanning and tin filtration, which is particularly important for lung imaging (e.g., to screen for lung cancer). It also uses some of the lowest radiation doses achievable for a CT of this class. For this reason, the SOMATOM go.Up is ideally suited for organizations that want to expand their portfolio.

Users of the SOMATOM go. platform can control routine examinations using only the tablet and remote, paving the way for a new, mobile workflow. Standardized work steps allow users to run the scan with just a few inputs. Automated postprocessing facilitates efficient scanner operation with zero-click reconstruction tasks that enable technologists with wide-ranging proficiency to generate consistent, high-quality studies. The standardization also provides radiologists with greater assurance regarding diagnostic image quality, helping them avoid errors and repeat scans, and thus unnecessary wait times.


Please enter your comment!
Please enter your name here